National Human Genome Resource Institute, “International Consortium Completes Map of Human Genetic Variation,”National Institutes of Health News, October 2005, available at <http://www.genome.gov/17015412> (last visited May 15, 2008).
2.
VenterJ. C., “Remarks at the Human Genome Announcement,”Functional & Integrative Genomics1, no. 3 (2000): 154–155.
3.
See e.g., DusterT., “Race and Reification in Science,”Science307, no. 5712 (2005): 1050–1051; KahnJ., “Misreading Race and Genomics after BiDil,”Nature Genetics37, no. 7 (2005): 655–656. Prior to this more recent shift to race in genetics, race was a controversial category of investigation in medical, epidemiological, and other kinds of clinical research throughout the 1990s. See e.g., OsborneN. G.FeitM. D., “The Use of Race in Medical Research,”JAMA267, no. 2 (1992): 275–279; WilliamsD. R., “Race and Health: Basic Questions, Emerging Directions,”Annals of Epidemiology7, no. 5 (1997): 322–333; WitzigR., “The Medicalization of Race: Scientific Legitimization of a Flawed Social Construct,”Annals of Internal Medicine125, no. 8 (1996): 675–679; FulliloveM. T., “Comment: Abandoning ‘Race’ as a Variable in Public Health Research — An Idea Whose Time Has Come,”American Journal of Public Health88, no. 9 (1998): 1297–1298. Special thanks to an anonymous reviewer for clarifying this point.
4.
RischN., “Dissecting Racial and Ethnic Differences,”New England Journal of Medicine354, no. 4 (2006): 408–411.
5.
AldhousP., “Geneticist Fears ‘Race-Neutral’ Studies Will Fail Ethnic Groups,”Nature418, no. 6896 (2002): 355–356; BurchardE. G., “The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice,”New England Journal of Medicine348, no. 12 (2003): 1170–1175; DaarA. S.SingerP. A., “Pharmacogenetics and Geographical Ancestry: Implications for Drug Development and Global Health,”Nature Reviews Genetics6, no. 3 (2005): 241–246; RischN., “Categorization of Humans in Biomedical Research: Genes, Race and Disease,”Genome Biology3, no. 7 (2002): 1–12.
6.
FosterM. W.SharpR. R., “Race, Ethnicity, and Genomics: Social Classifications as Proxies of Biological Heterogeneity,”Genome Research12, no. 6 (2002): 844–850; FosterM. W.SharpR. R., “Beyond Race: Towards a Whole-Genome Perspective on Human Populations and Genetic Variation,”Nature Reviews Genetics5, no. 10 (2004): 790–796.
7.
SankarP.ChoM. K., “Genetics: Toward a New Vocabulary of Human Genetic Variation,”Science298, no. 5597 (2002): 1337–1338, at 1338; see also KaplanJ. B.BennettT., “Use of Race and Ethnicity in Biomedical Publication,”JAMA289, no. 20 (2003): 2709–2716; “Ethnicity, Race, and Culture: Guidelines for Research, Audit, and Publication,”BMJ312, no. 7038 (1996): 1094; Race, Ethnicity, and Genetics Working Group, “The Use of Racial, Ethnic, and Ancestral Categories in Human Genetics Research,”American Journal of Human Genetics77, no. 4 (2005): 519–532.
8.
KeitaS. O. Y.BoyceA. J., Letter to the Editor, “‘Race’: Confusion about Zoological and Social Taxonomies, and Their Places in Science,”American Journal of Human Biology13, no. 5 (2001): 569–575, at 574–575; see also KeitaS. O. Y., “Conceptualizing Human Variation,”Nature Genetics36, Supplement 1 (2004): S17–S20; Risch, supra note 5.
9.
TaylorC., “The Politics of Recognition,” in GutmannA., ed., Multiculturalism (Princeton: Princeton University Press, 1994): 25–73.
10.
M'CharekA., “The Mitochondrial Eve of Modern Genetics: Of Peoples and Genomes, or the Routinization of Race,”Science as Culture14, no. 2 (2005): 161–183.
The International HapMap Consortium, “The International HapMap Project,”Nature426, no. 6968 (2003): 789–796.
13.
Samples from indigenous populations were not included in the HapMap. Some American Indian groups were consulted by the NHGRI in 2003: “Most of the attendees were not interested in tribal participation in such a study at this time, citing concerns that the HapMap will facilitate population-history studies and comparisons among populations.”Id., at 471.
14.
The International HapMap Consortium, “A Haplotype Map of the Human Genome,”Nature437, no. 7063 (2005): 1299–1320; The International HapMap Consortium, “A Second Generation Human Haplotype Map of Over 3.1 Million SNPs,”Nature449, no. 7164 (2007): 851–861.
15.
These populations were Maasai in Kinyawa, Kenya; Luhya in Webuye, Kenya; Chinese in metropolitan Denver, CO, U.S.A. area; Gujarati Indians in Houston, TX, U.S.A.; Toscani in Italia (Tuscans in Italy); African ancestry in the Southwest U.S.A.; and Mexican ancestry in Los Angeles, CA, U.S.A. These samples will be used to further validate and hone the HapMap. See Coriell Institute for Medical Research, “International HapMap Project,”available athttp://ccr.coriell.org/Sections/Collections/NHGRI/hapmap.aspx?PgId=266 (last visited May 15, 2008). In addition, the author was part of an NHGRI-sponsored team that participated in community consultation with and sample collection from Gujarati Indians from Houston.
LeeS. S.KoenigB. A., “Racial Profiling of DNA Samples: Will It Affect Scientific Knowledge about Human Genetic Variation?” in KnoppersB. M., ed., Populations and Genetics: Legal and Socio-Ethical Perspectives (Leiden and Boston: Martinus Nijhoff, 2003): At 231–244; OssorioP. N., “Race, Genetic Variation, and the Haplotype Mapping Project,”Louisiana Law Review66 (2005): 131–143.
18.
Cavalli-SforzaL. L., “The Human Genome Diversity Project: Past, Present and Future,”Nature Reviews Genetics6, no. 4 (2005): 333–340, at 333.
19.
ReardonJ., Race to the Finish: Identity and Governance in an Age of Genomics (Princeton: Princeton University Press, 2005).
20.
MarksJ., “‘We're Going to Tell These People Who They Really Are’: Science and Relatedness,” in FranklinS.McKinnonS., eds., Relative Values: Reconfiguring Kinship Studies (Durham, NC: Duke University Press, 2001): 355–383, at 380.
21.
GuerreroM. A. J., “Global Genocide and Biocolonialism: On the Effect of the Human Genome Diversity Project on Targeted Indigenous Peoples/Ecocultures as ‘Isolates of Historic Interest,’” in AldamaA. J., ed., Violence and the Body: Race, Gender, and the State (Bloomington: Indiana University Press, 2003): 171–188; HarryD., “The Human Genome Diversity Project: Implications for Indigenous Peoples,” in GrewalI.KaplanC., eds., An Introduction to Women's Studies: Gender in a Transnational World (Boston: McGraw-Hill, 2002): At 125–128. For a comprehensive discussion of the HGDP and its controversies, see Reardon, supra note 19.
22.
HarryD., Indigenous Peoples Council on Biocolonialism, “The Human Genome Diversity Project and Its Implications for Indigenous Peoples,” January 1995, available at <http://www.ipcb.org/publications/briefing_papers/files/hgdp.html> (last visited May 15, 2008).
23.
Morrison Institute for Population and Resource Studies, “Model Ethical Protocol for Collecting DNA Samples,”available at <http://www.stanford.edu/group/morrinst/hgdp/protocol.html> (last visited May 15, 2008); WeissK. M., “Proposed Model Ethical Protocol for Collecting DNA Samples,”Houston Law Review33, no. 5 (1997): 1431–1474; see also Reardon, supra note 19, at 98–155.
24.
Despite this failure, the original vision of HGDP scientists has continued in other forms including various diversity projects organized along nation-state lines as well as the privately-funded Genographic Project sponsored by National Geographic, IBM, and the Waite Family Foundation. See Cavalli-SforzaL. L., “Diversity Project Takes Time but Reaps Rewards,”Nature428, no. 6982 (2004): 467; Cavalli-Sforza, supra note 18; The Genographic Project, available at <https://www3.nationalgeographic.com/genographic/> (last visited May 15, 2008).
25.
The International HapMap Consortium, “Opinion: Integrating Ethics and Science in the International HapMap Project,”Nature Reviews Genetics5, no. 6 (2004): 467–475.
26.
David Altschuler, HapMap Researcher, interview with D. Rotman, “Genes, Medicine, and the New Race Debate,”Technology Review106, no. 5 (2003): 41–50, at 46.
27.
See The International HapMap Consortium, supra note 25, at 469.
28.
See Ossorio, supra note 17.
29.
See The International HapMap Consortium, supra note 25, at 469.
See, for example, MontpetitA., “An Evaluation of the Performance of Tag SNPs Derived from HapMap in a Caucasian Population,”PLoS Genetics2, no. 3 (2006): 282–290; PanditB., “A Detailed Hapmap of the Sitosterolemia Locus Spanning 69 kb; Differences between Caucasians and African-Americans,”BMC Medical Genetics7, no. 1 (2006): 1–11, available at <http://www.biomedcentral.com/1471–2350/7/13> (last visited May 15, 2008); TangH., “Genetic Structure, Self-identified Race/Ethnicity, and Confounding in Case-Control Association Studies,”American Journal of Human Genetics76, no. 2 (2005): 268–275. A full exploration of this research is beyond the scope of this paper, but there is nevertheless strong evidence to suggest that HapMap data not only has the potential to be used, but is already being used in medical genomics in ways that suggest the biological primacy of ancestry categories such as African, Asian, and European. Yet the specific ways in which researchers are using HapMap samples, and the implications thereof, have yet to be mapped.
32.
I further investigate these dynamics in a larger piece, “‘Frozen Moments’ in the HapMap: Some Ethnographic Speculations on Race, Human Genetic Variation Research, and Biomedicine” (in preparation).
33.
RoseN., The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century (Princeton: Princeton University Press, 2007).
34.
FoucaultM., The History of Sexuality (New York: Vintage Books, 1988); FoucaultM., Society Must Be Defended: Lectures at the Collège de France, 1975–76 (New York: Picador, 2003).
35.
I explore these questions in the specific context of the HapMap in another article, “From Practice to Substance: The Emergence of ‘Ethical Provenance’ in Human Genetic Variation Research” (in preparation).